Clinical trial
The Effectiveness and Safety of Artificial Oocyte Activation With Calcium Ionophore in Low Prognosis Women Classified as POSEIDON Group 4: a Randomized Clinical Trial
NCT05402605 is registered in ClinicalTrials.gov with Mỹ Đức Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness and Safety of Artificial Oocyte Activation With Calcium Ionophore in Low Prognosis Women Classified as POSEIDON Group 4: a Randomized Clinical Trial
- Lead sponsor
- Mỹ Đức Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 29, 2022
- Completion date
- June 30, 2024
- Enrollment
- 528 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
in vitro fertilization